ArticleJournal of cancer research and clinical oncology2021

Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma.

Jung Ho Im et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.